Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 9
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Isolated vaginal recurrence in women with stage I endometrial cancer.
Rios-Doria E, Cun HT, Filippova OT, Mueller JJ, Alektiar KM, Ellenson LH, Makker V, Lakhman Y, Leitao MM Jr, Jhingran A, Soliman PT, Abu-Rustum NR. Rios-Doria E, et al. Among authors: filippova ot. Gynecol Oncol. 2023 Dec;179:9-15. doi: 10.1016/j.ygyno.2023.10.011. Epub 2023 Oct 20. Gynecol Oncol. 2023. PMID: 37864854
The current clinical approach to newly diagnosed uterine cancer.
Filippova OT, Leitao MM. Filippova OT, et al. Expert Rev Anticancer Ther. 2020 Jul;20(7):581-590. doi: 10.1080/14737140.2020.1782750. Epub 2020 Jun 22. Expert Rev Anticancer Ther. 2020. PMID: 32531179 Free PMC article. Review.
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E, Filippova OT, Straubhar AM, Chi A, Awowole I, Sandhu J, Broach V, Mueller JJ, Gardner GJ, Jewell EL, Zivanovic O, Leitao MM Jr, Long Roche K, Abu-Rustum NR, Sonoda Y. Rios-Doria E, et al. Among authors: filippova ot. Gynecol Oncol. 2022 Nov;167(2):277-282. doi: 10.1016/j.ygyno.2022.08.017. Epub 2022 Sep 3. Gynecol Oncol. 2022. PMID: 36064678 Free PMC article.
Pattern of disease and response to pembrolizumab in recurrent cervical cancer.
Miller KM, Filippova OT, Hayes SA, Abu-Rustum NR, Aghajanian C, Broach V, Ellenson LH, Selenica P, Jewell EL, Kyi C, Lakhman Y, Mueller JJ, O'Cearbhaill RE, Park KJ, Sonoda Y, Zamarin D, Weigelt B, Leitao MM Jr, Friedman CF. Miller KM, et al. Among authors: filippova ot. Gynecol Oncol Rep. 2021 Jul 10;37:100831. doi: 10.1016/j.gore.2021.100831. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34345644 Free PMC article.
21 results